Acceleron  

PRESS RELEASES

  • Press Release
    Dec 23, 2011
    Acceleron Secures $30M Private Financing
    + VIEW FULL Press Release
  • Press Release
    Nov 28, 2011
    Acceleron Pharma to Present at Two Upcoming Investor Conferences
    + VIEW FULL Press Release
  • Press Release
    Sep 13, 2011
    Acceleron Initiates Phase 1 Study of ACE-536
    + VIEW FULL Press Release
  • Press Release
    Sep 12, 2011
    Acceleron Pharma to Present at Two September Investor Conferences
    + VIEW FULL Press Release
  • Press Release
    Aug 3, 2011
    Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-536 Program
    + VIEW FULL Press Release
  • Press Release
    Jun 2, 2011
    Celgene and Acceleron Initiate Phase 2/3 Study of ACE-011 (sotatercept) to Treat Chemotherapy-Induced Anemia in Patients with Lung Cancer
    + VIEW FULL Press Release
  • Press Release
    May 9, 2011
    Acceleron Pharma Presents Anabolic Bone Effects of ACE-661 at International Scientific Meeting
    + VIEW FULL Press Release
  • Press Release
    Apr 5, 2011
    Acceleron Presents Positive Results from Phase 1 Study of ACE-041 in Patients with Advanced Cancer
    + VIEW FULL Press Release
  • Press Release
    Mar 30, 2011
    Acceleron Pharma to Present at Two Upcoming Investor Conferences in April
    + VIEW FULL Press Release
  • Press Release
    Nov 29, 2010
    Acceleron Appoints Kevin F. McLaughlin as Senior Vice President and Chief Financial Officer
    + VIEW FULL Press Release
  • Press Release
    Nov 19, 2010
    Acceleron Announces Interim Findings from the ACE-041 Phase 1, First-in-Human Clinical Trial at 22nd EORTC-NCI-AACR Symposium
    + VIEW FULL Press Release
  • Press Release
    Nov 19, 2010
    Acceleron Announces Departure of Jasbir Seehra, Ph.D. Chief Scientific Officer
    + VIEW FULL Press Release
  • Press Release
    Nov 2, 2010
    Acceleron Awarded Grants from the Qualifying Therapeutic Discovery Project Program
    + VIEW FULL Press Release
  • Press Release
    Oct 13, 2010
    Acceleron Presents Preliminary ACE-031 Results from a Phase 1 Multiple Ascending Dose Study in Healthy Volunteers
    + VIEW FULL Press Release
  • Press Release
    Sep 15, 2010
    FierceBiotech Names Acceleron Pharma as One of the “Fierce 15” of 2010
    + VIEW FULL Press Release
  • Press Release
    Sep 9, 2010
    Acceleron Pharma Announces Joint Development and Commercialization Agreement with Shire on Novel Muscle Therapeutics for Orphan Diseases
    + VIEW FULL Press Release
  • Press Release
    Aug 19, 2010
    Acceleron Pharma Receives FDA Orphan Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy
    + VIEW FULL Press Release
  • Press Release
    Aug 4, 2010
    Acceleron Pharma Receives FDA Fast Track Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy
    + VIEW FULL Press Release
  • Press Release
    May 5, 2010
    Acceleron Pharma Initiates Phase 2 Clinical Trial with ACE-031 in Patients with Duchenne Muscular Dystrophy
    + VIEW FULL Press Release
  • Press Release
    Mar 23, 2010
    Acceleron and Collaborators Publish Two Papers on ACE-041, a Novel Angiogenesis Inhibitor
    + VIEW FULL Press Release
  • Press Release
    Mar 10, 2010
    Acceleron Recognized by The Wall Street Journal as One of the Top 50 Venture-Backed Companies in the United States
    + VIEW FULL Press Release
  • Press Release
    Mar 1, 2010
    Acceleron to Present at the Cowen and Company 30th Annual Health Care Conference
    + VIEW FULL Press Release
  • Press Release
    Jan 14, 2010
    Acceleron Pharma Announces Addition of Two Novel Programs to Development Pipeline at the 28th Annual JP Morgan Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    Jan 7, 2010
    Acceleron Pharma to Present at the 28th Annual J.P. Morgan Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    Dec 22, 2009
    Acceleron Pharma Expands Management Team with Two New Appointments
    + VIEW FULL Press Release
  • Press Release
    Dec 8, 2009
    Acceleron Pharma Presents Findings of ACE-536, a Novel Red Blood Cell-Forming Agent, at the 51st Annual Meeting of the American Society of Hematology
    + VIEW FULL Press Release
  • Press Release
    Dec 3, 2009
    Alkermes Licenses Technology Platform for Long-Acting Fusion Proteins from Acceleron Pharma
    + VIEW FULL Press Release
  • Press Release
    Dec 1, 2009
    Acceleron Pharma to Present Data on ACE-011 and ACE-536 at the 51st Annual Meeting of the American Society of Hematology
    + VIEW FULL Press Release
  • Press Release
    Nov 4, 2009
    Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
    + VIEW FULL Press Release
  • Press Release
    Sep 15, 2009
    Acceleron to Present at the UBS Global Life Sciences Conference
    + VIEW FULL Press Release
  • Press Release
    Sep 10, 2009
    Acceleron Pharma’s ACE-031 Increases Lean Body Mass in Phase 1 Single Dose Clinical Trial
    + VIEW FULL Press Release
  • Press Release
    Jul 30, 2009
    Acceleron to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    Jul 28, 2009
    Acceleron and Celgene Initiate Phase 2 Study of ACE-011 to Treat Chemotherapy-Induced Anemia
    + VIEW FULL Press Release
  • Press Release
    Jun 10, 2009
    Acceleron to Present ACE-031 Preclinical Study Results as Treatment for Loss of Muscle Mass and Function
    + VIEW FULL Press Release
  • Press Release
    Jun 9, 2009
    Acceleron Pharma to Present at Two Upcoming Investor Conferences
    + VIEW FULL Press Release
  • Press Release
    May 1, 2009
    Acceleron Selected as One of Boston Business Journal’s 2009 Best Places to Work
    + VIEW FULL Press Release
  • Press Release
    May 1, 2009
    Acceleron Announces Expansion of Cambridge Facilities by Additional 25% During Formal Unveiling of New Corporate Headquarters & Manufacturing Facility
    + VIEW FULL Press Release
  • Press Release
    Apr 14, 2009
    Acceleron Pharma Presents Preclinical Study Results for ACE-041 at the AACR 100th Annual Meeting 2009
    + VIEW FULL Press Release
  • Press Release
    Mar 29, 2009
    Acceleron to Present at the BioCentury Future Leaders in the Biotech Industry Conference
    + VIEW FULL Press Release
  • Press Release
    Mar 12, 2009
    Acceleron to Present at the Cowen and Company 29th Annual Health Care Conference
    + VIEW FULL Press Release
  • Press Release
    Jan 13, 2009
    Acceleron Introduces Breakthrough Program for Treatment of Anemia at the 27th Annual JP Morgan Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    Jan 6, 2009
    Acceleron to Present at the 27th Annual JP Morgan Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    Dec 18, 2008
    ACE-011 Phase 1 Results Published in the Journal of Bone and Mineral Research
    + VIEW FULL Press Release
  • Press Release
    Dec 3, 2008
    Celgene Corporation and Acceleron Pharma to Present ACE-011 Data at the 50th Annual Meeting of the American Society of Hematology
    + VIEW FULL Press Release
  • Press Release
    Nov 3, 2008
    Acceleron to Present at the Oppenheimer 19th Annual Health Care Conference
    + VIEW FULL Press Release
  • Press Release
    Oct 24, 2008
    Acceleron to Present at the 7th Annual Biotechnology Industry Organization Investor Forum
    + VIEW FULL Press Release
  • Press Release
    Oct 20, 2008
    Acceleron Initiates Phase 1 Clinical Trial for ACE-031 to Treat Diseases Involving Muscle Loss
    + VIEW FULL Press Release
  • Press Release
    Oct 16, 2008
    Celgene Corporation and Acceleron Pharma Initiate Phase 2 Study of ACE-011
    + VIEW FULL Press Release
  • Press Release
    Sep 30, 2008
    Acceleron to Present at Third Annual JMP Securities Healthcare Focus Conference
    + VIEW FULL Press Release
  • Press Release
    Sep 22, 2008
    Acceleron Pharma Acknowledged for Positive Impact on Economic Development in Massachusetts
    + VIEW FULL Press Release
  • Press Release
    Sep 19, 2008
    Acceleron to Present at the UBS Global Life Sciences Conference
    + VIEW FULL Press Release
  • Press Release
    Jun 20, 2008
    Acceleron to Present at the Jefferies 2nd Annual Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    Jun 16, 2008
    Acceleron Doubles Laboratory and Manufacturing Space and Increases Headcount by 40%
    + VIEW FULL Press Release
  • Press Release
    Jun 4, 2008
    Acceleron to Present at the Needham & Company 7th Annual Biotechnology and Medical Technology Conference
    + VIEW FULL Press Release
  • Press Release
    May 13, 2008
    Acceleron to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    May 7, 2008
    ACE-011 Preclinical Data Published in the Proceedings of the National Academy of Sciences
    + VIEW FULL Press Release
  • Press Release
    Mar 24, 2008
    Acceleron Pharma and Celgene Corporation Receive Hart-Scott-Rodino Clearance for ACE-011 Collaboration
    + VIEW FULL Press Release
  • Press Release
    Mar 11, 2008
    Acceleron to Present at the Cowen and Company 28th Annual Health Care Conference
    + VIEW FULL Press Release
  • Press Release
    Feb 20, 2008
    Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-011 Program for Cancer-Related Bone Loss
    + VIEW FULL Press Release
  • Press Release
    Jan 23, 2008
    Acceleron Pharma Receives Grant for ACE-011 from the Multiple Myeloma Research Foundation
    + VIEW FULL Press Release
  • Press Release
    Nov 20, 2007
    Acceleron Pharma to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    Nov 1, 2007
    Acceleron Pharma to Present at the Massachusetts Biotechnology Council’s 9th Annual MASS Opportunities Investment Conference
    + VIEW FULL Press Release
  • Press Release
    Oct 31, 2007
    Acceleron Pharma to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    Oct 30, 2007
    Acceleron Pharma Completes $31M Series C Financing
    + VIEW FULL Press Release
  • Press Release
    Oct 18, 2007
    Acceleron Pharma’s ACE-031 Increases Muscle Mass In a Preclinical Model of Glucocorticoid-induced Muscle Loss
    + VIEW FULL Press Release
  • Press Release
    Oct 4, 2007
    Acceleron Pharma Website Awarded “Pharmaceutical Industry Standard of Excellence” by the Web Marketing Association
    + VIEW FULL Press Release
  • Press Release
    Oct 2, 2007
    Acceleron Pharma to Present at the Natixis Bleichroeder Hidden Gems Conference
    + VIEW FULL Press Release
  • Press Release
    Sep 24, 2007
    Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
    + VIEW FULL Press Release
  • Press Release
    Sep 20, 2007
    Acceleron Pharma’s ACE-011 Increases Bone Mineral Density and Bone Strength in Preclinical Studies in Non-Human Primates
    + VIEW FULL Press Release
  • Press Release
    Sep 20, 2007
    Acceleron Pharma to Present at the UBS 2007 Global Life Sciences Conference
    + VIEW FULL Press Release
  • Press Release
    Sep 18, 2007
    Acceleron Pharma Presents Positive Phase 1 Results Demonstrating ACE-011 Increases Markers of Bone Formation
    + VIEW FULL Press Release
  • Press Release
    Sep 18, 2007
    Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
    + VIEW FULL Press Release
  • Press Release
    Aug 6, 2007
    Acceleron Pharma to Present ACE-011 Bone Growth Data at the ASBMR 29th Annual Meeting
    + VIEW FULL Press Release
  • Press Release
    Jul 31, 2007
    Acceleron Pharma to Present at the 27th Annual Canaccord Adams Global Growth Conference
    + VIEW FULL Press Release
  • Press Release
    Jun 27, 2007
    ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
    + VIEW FULL Press Release
  • Press Release
    May 14, 2007
    Acceleron Pharma’s ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
    + VIEW FULL Press Release
  • Press Release
    Apr 25, 2007
    Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Managemen
    + VIEW FULL Press Release
  • Press Release
    Mar 29, 2007
    Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
    + VIEW FULL Press Release
  • Press Release
    Mar 7, 2007
    Acceleron Pharma to Present at the Cowen 27th Annual Health Care Conference
    + VIEW FULL Press Release
  • Press Release
    Nov 3, 2006
    Acceleron Pharma to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
    + VIEW FULL Press Release
  • Press Release
    Oct 30, 2006
    Acceleron Pharma to Present at the MBC’s MASS Opportunities Conference
    + VIEW FULL Press Release
  • Press Release
    Sep 18, 2006
    Acceleron Pharma Presents ACE-011 Preclinical Data Demonstrating Both Anabolic and Anti-Resorptive Properties
    + VIEW FULL Press Release
  • Press Release
    Sep 12, 2006
    Acceleron Pharma to Present ACE-011 Preclinical Data at the Annual Meeting of the American Society for Bone and Mineral Research
    + VIEW FULL Press Release
  • Press Release
    Aug 2, 2006
    Acceleron Pharma Closes $30M Series B Financing
    + VIEW FULL Press Release
  • Press Release
    Jun 21, 2006
    Acceleron Initiates Phase 1 Clinical Trial of ACE-011, a Novel Treatment for Bone Loss
    + VIEW FULL Press Release
  • Press Release
    May 16, 2006
    Acceleron Pharma Appoints Matthew L. Sherman, M.D. as Chief Medical Officer
    + VIEW FULL Press Release
  • Press Release
    Jun 14, 2004
    Acceleron Pharma Appoints Glenn Batchelder as CEO and Adds Richard F. Pops to Board of Directors
    + VIEW FULL Press Release
  • Press Release
    Feb 13, 2004
    Acceleron Pharma, Developing Drugs to Treat Musculoskeletal and Metabolic Disorders, Secures $25 Million in Series A Funding
    + VIEW FULL Press Release